Clinical Trial Update: Cardiopulmonary Outcomes in Osteogenesis Imperfecta: BBD7708

View source ↗

Summary

This update notes that the clinical trial assessing BBD7708 for cardiopulmonary outcomes in osteogenesis imperfecta is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteogenesis Imper Imperfecta

Drugs mentioned

• BBD7708

Snippet

Sponsor: Baylor College of Medicine | Conditions: Osteogenesis Imperfecta | Status: ACTIVE_NOT_RECRUITING